[250 Pages Report] The immunochemistry products market is anticipated to record a CAGR of 7.25% during the forecast period, up from US$ 2.08 Bn in 2021 to reach a valuation of US$ 4.5 Bn by 2032.
The immunochemistry products market is anticipated to show promising growth owing to its increase used to treat various illnesses and chronic diseases.
| Attributes | Details |
|---|---|
| Immunochemistry Products Market Value (2021) | US$ 2.08 Billion |
| Immunochemistry Products Market Value (2032) | US$ 4.5 Billion |
| Immunochemistry Products Market CAGR (2022-2032) | 7.25% |
Sales of immunochemistry products are expected to rise as IHC (Immunochemistry) has grown in prominence in clinical diagnostics. As a result, the rising frequency of chronic illnesses is expected to boost demand for immunohistochemistry products, adding to immunochemistry market development.
Increasing number of patients with various diseases such as cardiovascular disorders and cancer is also projected to contribute to the growth of the immunochemistry products market share. Immunohistochemistry products are most widely utilized in cancer detection and treatment. Aside from that, the alarming increase in medical and healthcare spending, as well as the increasing focus on value-based healthcare solutions, are significantly boosting the sales of immunohistochemistry products and propelling the immunohistochemistry products market growth.
The report sheds light on the factors improving the sales of immunochemistry products, and, in turn, the opportunities for the market players. However, the immunochemistry products market also faces some challenges, which might limit the immunochemistry products market share from reaching its potential.
Some of the key immunochemistry products market trends promoting the demand for immunochemistry products include technological innovation and increased knowledge of novel diagnostic tools among medical professionals, as well as the availability of reimbursements for IHC tests, which have all been projected to favorably impact the growth of the global immunochemistry market.
Moreover, personalized medicine has shown to be incredibly beneficial for patients with non-small-cell lung cancer, and its usage is predicted to have a significant impact on sales of immunohistochemistry products. The creation of multiplex and mutation-specific immunochemistry tests is a significant advancement that is anticipated to boost the immunochemistry products market during 2022-2032.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Cancer's rising incidence rate is anticipated to drive up the sales and demand for immunochemistry products throughout the forecasted period. As immunochemistry products are widely used to diagnose cancer and other disorders involving antigen-antibody reactions.
According to the National Institutes of Health (NIH), an estimated 1,735,350 new cancer cases were discovered in the United States in 2018, with 609,640 individuals dying from the illness, this factor had a great impact on the sales of immunochemistry products. Furthermore, the expanding geriatric population and the increasing number of diagnostic facilities are driving demand for Immunochemistry products and market development.
Biotechnology companies' increasing spending in research and development programmes and innovative strategies to increase the sales and demand for immunochemistry products are also positively impacting the immunochemistry products market growth.
Depending on geographic regions, global immunochemistry market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.
North America followed by Europe dominates the global immunochemistry market due to the easing number of patients with cardiovascular disorder and cancers, growing aging population, developed healthcare infrastructure, and growing demand for immunochemistry products or immunoassay technologies in these regions. This region is also anticipated to record an increase in revenue generated by sales of immunochemistry products by key players.
Asia-Pacific is the fastest emerging market for global immunochemistry due to growing patient population with cardiac diseases, increasing awareness about advanced immunochemistry products available in the immunochemistry products market, developing healthcare infrastructure and rising government spending in healthcare industry in this region.
Principal Consultant
Some of the key players in global immunochemistry market are F. Hoffmann-La Roche Ltd, Siemens Healthcare, Danaher Corporation, ImmunoChemistry Technologies, LLC, Beckman Coulter Inc., Ortho Clinical Diagnostics and Thermo Fisher Scientific Inc.
The report consists of key players contributing to the immunochemistry products market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions. This exclusive report analysis the competitive landscape and Immunochemistry Products market share acquired by players to strengthen their market position.
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 7.25% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 - 2020 |
| Forecast period | 2022 - 2032 |
| Quantitative units | Revenue in USD million, volume in units, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Product, application, end user, region |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand |
| Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | AGC Inc.; Cevital Group; Euroglas; Guardian Industries; Saint-Gobain; Vitro |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The immunochemistry products market is forecasted to register a CAGR of 7.25% during the forecast period.
Key players holding substantial Immunochemistry Products market share include F. Hoffmann-La Roche Ltd, Siemens Healthcare, Danaher Corporation, ImmunoChemistry Technologies, LLC, Beckman Coulter Inc., Ortho Clinical Diagnostics and Thermo Fisher Scientific Inc.
As per the analysis, the immunochemistry products market share is likely to be US$ 4.5 Bn by 2032.
Demand for immunochemistry products is likely to rise on the back of an increasing number of patients with various diseases such as cardiovascular disorders and cancer.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Immunochemistry Products Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Immunochemistry Products Market Analysis 2017-2021 and Forecast 2022-2032, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2022-2032
5.3.1. Instruments
5.3.2. Consumables
5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Type, 2022-2032
5.5.1.1.1. Deep-dive segmentation will be available in the sample on request
6. Global Immunochemistry Products Market Analysis 2017-2021 and Forecast 2022-2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
6.3.1. Infectious Diseases
6.3.2. Blood Disorder
6.3.3. Drug of Abuse Testing
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
6.5.1.1.1. Deep-dive segmentation will be available in the sample on request
7. Global Immunochemistry Products Market Analysis 2017-2021 and Forecast 2022-2032, By End Users
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End Users, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Users, 2022-2032
7.3.1. Medical Research Labs
7.3.2. Hospitals
7.3.3. Clinical Diagnostic
7.3.4. Biopharmaceutical & Biotechnology Companies
7.3.5. Others
7.4. Y-o-Y Growth Trend Analysis By End Users, 2017-2021
7.5. Absolute $ Opportunity Analysis By End Users, 2022-2032
7.5.1.1.1. Deep-dive segmentation will be available in the sample on request
8. Global Immunochemistry Products Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia & Pacific
8.3.6. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Immunochemistry Products Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.K.
9.2.1.2. Canada
9.2.2. By Type
9.2.3. By Application
9.2.4. By End Users
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By Application
9.3.4. By End Users
9.4. Key Takeaways
10. Latin America Immunochemistry Products Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Type
10.2.3. By Application
10.2.4. By End Users
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Application
10.3.4. By End Users
10.4. Key Takeaways
11. Europe Immunochemistry Products Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Type
11.2.3. By Application
11.2.4. By End Users
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Application
11.3.4. By End Users
11.4. Key Takeaways
12. East Asia Immunochemistry Products Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Type
12.2.3. By Application
12.2.4. By End Users
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Application
12.3.4. By End Users
12.4. Key Takeaways
13. South Asia & Pacific Immunochemistry Products Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Indonesia
13.2.1.4. Malaysia
13.2.1.5. Singapore
13.2.1.6. Australia
13.2.1.7. New Zealand
13.2.1.8. Rest of South Asia & Pacific
13.2.2. By Type
13.2.3. By Application
13.2.4. By End Users
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Application
13.3.4. By End Users
13.4. Key Takeaways
14. MEA Immunochemistry Products Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Type
14.2.3. By Application
14.2.4. By End Users
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By Application
14.3.4. By End Users
14.4. Key Takeaways
15. Key Countries Immunochemistry Products Market Analysis
15.1. U.K.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Type
15.1.2.2. By Application
15.1.2.3. By End Users
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Type
15.2.2.2. By Application
15.2.2.3. By End Users
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Type
15.3.2.2. By Application
15.3.2.3. By End Users
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Type
15.4.2.2. By Application
15.4.2.3. By End Users
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Type
15.5.2.2. By Application
15.5.2.3. By End Users
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Type
15.6.2.2. By Application
15.6.2.3. By End Users
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Type
15.7.2.2. By Application
15.7.2.3. By End Users
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Type
15.8.2.2. By Application
15.8.2.3. By End Users
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Type
15.9.2.2. By Application
15.9.2.3. By End Users
15.10. China
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Type
15.10.2.2. By Application
15.10.2.3. By End Users
15.11. Japan
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Type
15.11.2.2. By Application
15.11.2.3. By End Users
15.12. South Korea
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Type
15.12.2.2. By Application
15.12.2.3. By End Users
15.13. India
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Type
15.13.2.2. By Application
15.13.2.3. By End Users
15.14. Thailand
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Type
15.14.2.2. By Application
15.14.2.3. By End Users
15.15. Indonesia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Type
15.15.2.2. By Application
15.15.2.3. By End Users
15.16. Malaysia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Type
15.16.2.2. By Application
15.16.2.3. By End Users
15.17. Singapore
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Type
15.17.2.2. By Application
15.17.2.3. By End Users
15.18. Australia
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Type
15.18.2.2. By Application
15.18.2.3. By End Users
15.19. New Zealand
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Type
15.19.2.2. By Application
15.19.2.3. By End Users
15.20. GCC Countries
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Type
15.20.2.2. By Application
15.20.2.3. By End Users
15.21. South Africa
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2021
15.21.2.1. By Type
15.21.2.2. By Application
15.21.2.3. By End Users
15.22. Israel
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2021
15.22.2.1. By Type
15.22.2.2. By Application
15.22.2.3. By End Users
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Type
16.3.3. By Application
16.3.4. By End Users
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. ImmunoChemistry Technologies, LLC
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Thermo Fisher Scientific
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Capricorn Products LLC
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Roche Diagnostics International Ltd
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. BioMérieux
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Beckman Coulter
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Siemens AG
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Tosoh Corporation
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Bio-Rad
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Abbott
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Immunochemistry Products Market
